IAS 2027, the 14th IAS Conference on HIV Science, will take place in Geneva, Switzerland, and virtually from 11 to 15 July 2027. Around 5,000 people from more than 130 countries are expected to attend.

The IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. Through its open and inclusive programme, the meeting sets the gold standard of HIV science, featuring latest HIV research and innovations that move science into policy and practice.

AIDS 2026, the 26th International AIDS Conference, took place in Rio de Janeiro, Brazil, and virtually from the 26-31 July 2026. Under the theme Rethink. Rebuild. Rise. it took place at a defining moment for the global HIV response. Alongside the latest research, discussions focused on scaling up long-acting HIV prevention, strengthening health systems, advancing country ownership, and ensuring the future of HIV prevention remains rooted in innovation, implementation and sustained investment.

AVAC’s resources, events and insights from the conference are below.

---

Check out AVAC’s Highlights from the Meeting

• The State of HIV Prevention: Big News, Big Moves: Reflections from AIDS 2026 in Rio de Janeiro, Brazil — August 18, 2026
• Beyond AIDS 2026: AVAC’s Top 10 — August 5, 2026
• AIDS 2026: Rising Above to Meet the Moment — August 5, 2026
• Innovation Without Access is Injustice: AIDS 2026 Opens in Rio — July 28, 2026
• Science, Systems, and Communities: Turning Progress into Impact — July 30, 2026

---

Looking for key takeaways from the conference?

Watch here for highlights of the meeting from AVAC’s executive director, Mitchell Warren.

---

AVAC Session Roadmaps

---

Resources

AVAC’s latest infographics on the research and development pipeline, prevention options, and the impact of US funding cuts can be accessed here.

---

Resource Hubs

---

Pre-conferences, Satellites, Sessions and Workshops Featuring AVAC and Partners

Sunday, 26 July

• Pre-conference: Advancing HIV prevention science and access
  08:00 – 19:00
  Hosted by the International AIDS Society, this pre-conference features six sessions showcasing the latest advances in HIV prevention science and access—including the Global Forecast of Long-Acting PrEP Need for Key Populations (2025–2030), developed jointly by GBGMC and AVAC. AVAC board, staff and partners will also explore the science behind next-generation HIV vaccine candidates and how to translate.

Monday, 27 July

• Satellite: Shared pipeline; shared goal: Innovations in long-acting antiretrovirals for PrEP, PEP and treatment
  11:30 – 12:30 
  Organized by AVAC, this session will bring together researchers, product developers, donors, advocates and other partners to explore the future of long-acting antiretroviral (ARV) innovation for PrEP, PEP and treatment.

Tuesday, 28 July

• Symposium: bNAbs for cure: Hope or hype?
  10:30-11:30
  AVAC Board Member Marina Caskey will present in this symposium exploring the promise—and limitations—of broadly neutralizing antibodies (bNAbs) for HIV cure.

Wednesday, 29 July

• Symposium: Leadership at the tipping point: Protecting the gains and advancing progress in a new era of the HIV response
  10:30-11:30
  Moderated by AVAC’s Mitchell Warren and HER Voice Fund Ambassador Nomonde Ngema, this symposium explores the future of the global HIV response amid shifting political priorities and an evolving global health landscape.

• Satellite: Choosing impact: Making long-acting HIV prevention a reality for key populations in sub-Saharan Africa
  12:00 – 13:00
  Organized by Global Black Gay Men Connect (GBGMC) with AVAC and a number of partners participating, this session will examine strategies to sustain and expand HIV prevention for key populations as long-acting prevention options become available.

• Satellite: To fund or not to fund: Pathways and proof points to sustaining HIV prevention as part of integrated approaches and health financing reforms
  18:00 – 19:30
  Organized by PATH, AVAC, UNAIDS, WHO, Unitaid, APCOM, ICWEA, Harvard, Frontline AIDS and the Elton John AIDS Foundation, this session will examine the growing HIV prevention funding crisis and what’s needed to sustain progress.

Thursday, 30 July

• Workshop: Skills Lab: Community-led monitoring
  12:00 – 13:30
  Facilitated by the International Treatment Preparedness Coalition (ITPC), NACOSA, the Network of Journalists Living with HIV (JONEHA) and community monitoring experts, including AVAC Senior Advisor Maureen Luba, this interactive workshop will strengthen practical skills in community-led monitoring (CLM).

• Symposium: From community to innovation to scale
  16:30 – 17:30
  AVAC’s Grace Kumwenda will join community leaders, researchers, clinicians, policymakers and funders to discuss the partnerships, inclusive research and implementation strategies needed to accelerate innovation and ensure equitable access from the outset.

• Satellite: From choice to impact: Long-acting and multipurpose HIV prevention technologies
  18:00 – 19:30
  Hosted by IPM South Africa, AVAC and Access Bridge’s Kate Segal and Ascend Futures Foundation’s Chilufya Kasanda will join researchers, advocates, implementers and policymakers to examine the latest scientific advances, implementation strategies and pathways to equitable access for long-acting options and MPTs.

Friday, July 31

• Symposium: The promises of long-acting injectable PrEP for HIV prevention
  10:30 – 11:30
  Access Bridge Executive Director Wawira Nyagah share community perspectives on early implementation of injectable cabotegravir and lenacapavir, identifying remaining gaps, and discussing strategies to accelerate equitable rollout.

---

HIV Cure Research at AIDS 2026

Explore HIV cure research sessions at AIDS 2026 with Treatment Action Group (TAG)’s curated list of conference sessions and events.

---

Both a Question and an Answer to Integration

Introducing the Dual Prevention Pill (DPP) will require integration of contraception and PrEP in guidelines, health systems, delivery approaches, and demand creation. Join us to discuss how programs should think about rolling out novel prevention products like the DPP in the current landscape, learning from projects across sub-Saharan Africa.

Moderator

• Isolde Birdthistle, London School of Hygiene & Tropical Medicine

Speakers

• Dr. Lori Miller, IPPF
• Nelia Banda, CHAI
• Rhoda Msiska, Copper Rose Zambia

PDF version of flyer also available.

Since its inaugural convening in Kampala, Uganda in 2009, the International Conference on Family Planning (ICFP) has grown into more than just a conference. It has become a global community, a dynamic movement, and a trusted digital platform advancing sexual and reproductive health and rights (SRHR) for all.

ICFP brings together researchers, governments, advocates, health equity champions, and local communities to celebrate progress, pledge new commitments, and chart the way forward. Rooted in collaboration, inclusivity, innovation, and scientific integrity, it serves as a strategic inflection point for advancing universal access to family planning and reproductive health.

The ICFP 2025 theme, “Equity Through Action: Advancing Sexual and Reproductive Health and Rights for All,” reflects the urgency of addressing systemic inequities through innovative solutions and concrete commitments. Participants will have access to a wide range of sessions—from plenaries, panel discussions, and debates to workshops, side events, and networking opportunities—all designed to spark dialogue, strengthen partnerships, and inspire action.

↪ Click for IAS 2025 resources and for our updates from the conference

The IAS 2025 conference in Kigali will go down as a critical turning point in the history of the HIV response. Every session, every meeting, every presentation played out against an existential threat: will the world find the courage and political will to end the HIV epidemic, with tremendous advances in technology underway, or will the momentum seen through 2024 collapse as evidence-based interventions fall way to ideology?

Leaders across the field are persevering to push forward the science, policies, programs and partnerships that are essential to achieve impact; and they are calling for solidarity. Advocates are leading the way, cutting a path and demanding equity, human rights and community leadership. WACI Health’s Rosemary Mburu captured this call to action at the opening session, saying “Community action is not the soft side of science — it’s what gives science its soul, its reach, and its relevance.” 

New research on the HIV prevention pipeline is expected to be shared alongside evidence on how the dismantling of foreign aid and the retreat from US commitments to science and global health are impacting lives and livelihoods. Every aspect of the HIV response is under attack — from basic research and clinical development to policy, programs, and global access to life-saving treatment and prevention.

See AVAC’s new report, which lays out what’s needed at this critical time to get HIV prevention into the hands of those that need it most, and join us Monday, July 14 for a satellite session, Re-imagining prevention: Ensuring sustainable PrEP access in an evolving funding context.

---

IAS 2025 Resources

Use AVAC’s Roadmap to find sessions where prevention and the larger issues of global health equity and sustainability are in the spotlight. You can download it as a sortable spreadsheet or PDF. 

AVAC Updates from the Conference

• Day 1 at IAS 2025: Funding cliffs, epidemic-ending possibilities, and essential advocacy
• Additional IAS highlights in Global Health Watch
• From Kigali: At IAS 2025, the HIV response rallies to face the crises

AVAC Conference Presentations

• Integration 2025: Where are we with sexual & reproductive health and HIV
• Re-imagining Prevention: Planning for sustainable PrEP access in the new funding context
• HIV Research on Pause: Impacts of US government cuts on HIV R&D, especially on HIV cure research
• No Retreat, No Surrender: Sustaining the HIV response in times of turmoil
• Designing for the Future: Community perspectives for HIV prevention trials
• Policy Shifts Needed to Enable PrEP Private Sector Delivery: Harnessing private sector strategies to expand access to PrEP
• How Have Policies Influenced PrEP Uptake: An analysis of PrEP data in 139 countries

Satellites, Sessions and Panels featuring AVAC and Partners 

(All times listed are local in Kigali, Rwanda. See the time zone converter here.) 

Sunday, July 13

• Expanding PrEP Access: The Role of HIVST in Uptake and Scale-Up – HIV Self-Testing impact on HIV diagnosis and treatment, Preconference, 09:00 – 17:45
• Building resilience: Strengthening national leadership, integration, and sustainable HIV programs in an era of funding transition – Sustaining HIV Prevention and Introducing / Scaling Long-Acting Prevention Tools: Navigating a Way Forward in the Current Environment, Preconference, 14:00 – 17:45
• Co-infections, viral and host diversity: Impact on HIV cure, Preconference, 9:00 – 17:45, featuring update from AVAC and partners on community perspectives and implications of US government funding issues 
• Success stories and future directions in African HIV vaccine research – Clinical research successes and lessons learnt, Preconference, 9:00-12:45

Monday, July 14

• Re-imagining prevention: Planning for sustainable PrEP access in the new funding context, Satellite, 09:30 – 11:00, sponsored by AVAC and the Ministry of Health of Zambia
• Consolidating and advancing African leadership of HIV Cure strategies to accelerate cure research for Africa and the world, Satellite, 11:30 – 12:30
• The future of person-centred HIV prevention: Latest evidence from the African continent, Satellite, 11:30 – 12:30
• What’s new in WHO guidelines: Advancing prevention, testing, and treatment for impact and sustainability, Satellite, 13:00 – 14:30, including the launch of new LEN for PrEP guidelines
• Towards the finish line: Leveraging science to accelerate progress, sustain impact, and shape the future of HIV, Satellite, 15:00 – 16:30
• 2025: Time to bring HIV, sexual and reproductive health together for better care, Satellite, 15:00 – 16:30

Tuesday, July 15

• From PrEP to harm reduction: Scaling up comprehensive HIV prevention strategies, Oral abstract, 10:45 – 11:45
• How Long-Acting Drugs Can Help End the HIV Pandemic in Africa, Sponsor satellite, 12:15 – 13:15
• Confronting the storm: The future of the HIV response, Special session, 13:30 – 14:45
• No retreat, no surrender: Sustaining the HIV response in times of turmoil, Oral abstract, 15:00 – 16:00, featuring AVAC’s Richard Muko presenting about COMPASS’s comparative analysis of country policies and practices on domestic resource mobilization
• Health equity in challenging times: Threats and opportunities, Oral abstract, 16:30 – 17:30, moderated by AVAC’s Mitchell Warren
• Harnessing the private sector to deliver HIV prevention, Sponsor satellite, 18:00 – 19:30, featuring AVAC’s Catherine Verde Hashim presenting on policy shifts needed to deliver HIV prevention through the private sector
• The future of HIV prevention clinical trials, Satellite, 18:00 – 19:30, featuring AVAC’s Grace Kumwenda presenting on community perspectives in HIV prevention clinical research

Wednesday, July 16

• Implementation of long-acting PrEP in real world settings – the ImPrEP Project, Satellite, 12:15 – 13:15
• Co-Chair’s choice, Oral abstract, 15:00 – 16:00, featuring a presentation of the Phase 2 safety and pharmacokinetic study of MK-8527 as once-monthly oral PrEP
• Let’s get real: Implementing PrEP choice in practice, Symposium, 15:00 – 16:00
• Developing objective targets for monitoring PrEP program progress, Satellite, 18:00 – 19:30

Thursday, July 17

• Getting to grips with prevention, Plenary, 09:00 – 10:30, featuring updates on HIV vaccine discovery medicine and evidence-based innovations to simplify and de-medicalize PrEP choice
• Purposeful PrEP: New insights on lenacapavir for prevention, Oral abstract, 10:45 – 11:45
• Big money and the big picture: Funding and HIV epidemiology, Oral abstract, 12:15 – 13:15, featuring an AVAC presentation on how policies influenced PrEP uptake
• Pregnancy and long-acting ARVs for prevention and treatment, Symposium, 13:45 – 14:45, featuring AVAC partner Chilufya Kasanda of Ascend Futures Foundation in Zambia and updates from Merck, ViiV and Gilead on their respective PrEP programs